Data for Benign Musculoskeletal Tumors

 
Print this page/section and all subsectionsPrint this page/section and all subsections
VIIIA.D.0.1

Lead Author(s): 

William G. Ward SR, MD
Robert M. Corey, MD

Supporting Author(s): 

Sylvia I. Watkins-Castillo, PhD

The relative frequency of more common benign bone tumors has been discerned from prior publications and extrapolation from the primary contributor’s case registry of consecutive surgical cases treated between 1991 through 2004. It should be noted that although Dr. Ward’s personal tumor registry has been updated since 2004, in 2005 additional providers joined his group and began to share care for this cohort of patients. With the resulting tempering in his experience, accurate incidence estimates could no longer be extrapolated from his personal tumor database. Table 9A.7.1 reflects the collected experience reported in the Mayo Clinic publication of 1986, the University of Florida publication from 1983, the J. Mirra experience reported in 1989, and the case series reflecting the practice of Dr. Ward, a full-time solo orthopaedic oncologist in practice from 1991 to 2004, at Wake Forest University Health Sciences in Winston-Salem, NC.

The experience of Dr. Ward during the stated time-period is believed to reflect roughly the general prevalence of bone and soft tissue tumors, since he treated a wide variety of benign and malignant bone tumors in a broad referral practice. All cases in his registry reflected his personally treated patients, ie, none were “consult cases” in which only radiographs or pathology slides were reviewed for outside consulting physicians, such as the Mayo and Mirra series included in their registries. The earlier data sets were accumulated during time periods prior to the full development of the subspecialty of orthopaedic oncology; thus, only the more unusual cases of bone tumors were referred to major medical centers, making estimates of their incidence less reliable. It is believed that, with the exception of bone cysts, general orthopaedic surgeons or other musculoskeletal specialists in North Carolina treated few bone tumors over the period the data was collected, as most were referred to orthopaedic oncologists. Practical experience has confirmed that osteosarcoma is the least likely sarcoma to be treated by anyone other than an orthopaedic oncologist. Dr. Ward and a small group of orthopaedic oncologists treated nearly all patients with an osteosarcoma in North Carolina for the past 22+ years.

As such, comparing the cases of benign bone tumors relative to the cases of osteosarcoma treated by Dr. Ward provides a relative index useful in generating a broad estimate of the prevalence of these benign tumors. By comparing this estimate with the national estimate for the annual occurrence of osteosarcoma, the most commonly encountered primary sarcoma of bone, a rough estimate of the incidence and prevalence of these benign bone tumor diseases was calculated. Because the records only included patients treated surgically, incidence and prevalence estimates also include only patients with these disease states that generally require surgical intervention. This selection process likely excludes small benign tumors, thereby artificially lowering the frequency estimates. (Reference Table 8A.7.1 PDF CSV)

Edition: 

  • 2014

Chapter Graphs

To save an individual graph, right-click and select Save Image As

Topic Tables

Click on an image to view PDF